Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Amyotrophic lateral sclerosis (ALS) is an adult‐onset fatal neurodegenerative disease which lacks identified biological markers. A label‐free plasma surface‐enhanced Raman spectroscopy (SERS) method was developed to explore a simple and noninvasive test for ALS.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>ALS patients were enrolled serially and plasma samples were collected at the time of diagnosis prior to the start of ALS treatment. SERS spectra were recorded using a Renishaw micro‐Raman system.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>To exclude the interference by varying disease severity, we enrolled three groups of ALS patients, including ALS‐1 (<i>n</i> = 60; ALSFRS‐R ≥ 42 and time interval ≤ 12 months), ALS‐2 (<i>n</i> = 61; ALSFRS‐R < 42 and time interval ≤ 12 months), and ALS‐3 (<i>n</i> = 61; ALSFRS‐R ≥ 38 and time interval> 12 months). The SERS spectra were analyzed using principal component analysis (PCA), which showed that ALS‐1, ALS‐2, ALS‐3, and control groups were separated significantly. Then, decision tree (DT) models and receiver operating characteristic curves were employed and identified that bands at 722 and 739 cm<sup>−1</sup>, and ratios of 635–722 cm<sup>−1</sup> and 635–739 cm<sup>−1</sup> were able to distinguish ALS from controls significantly. Finally, we highlighted six metabolism pathways correlated with ALS, including phenylalanine‐tyrosine‐tryptophan biosynthesis, aminoacyl‐tRNA biosynthesis, phenylalanine metabolism, pantothenate and CoA biosynthesis, porphyrin and chlorophyll metabolism, and pyrimidine metabolism. </p><p><b>Interpretation:</b></p><p>Plasma SERS could be a promising tool for the detection of ALS. The bands at 722 and 739 cm<sup>−1</sup>, and the ratios of 635–722 cm<sup>−1</sup> and 635–739 cm<sup>−1</sup> could serve as potential indicator for ALS. </p></section>

SERS "hot spot" enhance-array assay for misfolded SOD1 correlated with white matter lesions and aging

Detection the mutated protein aggregation and mitochondrial function in fibroblasts from amyotrophic lateral sclerosis patients with SOD1 gene mutations

Quantitative and Specific Detection of Blood Biomarkers for Accurate Prediction of White Matter Lesions with Cognitive Dysfunction Using Dendrite Gold Nanostar-Based Surface-Enhanced Raman Scattering Barcode Chips

Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging

Chemoselective Bioconjugation of Amyloidogenic Protein Antigens to PEGylated Microspheres Enables Detection of α-Synuclein Autoantibodies in Human Plasma

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

MS785-MS27 Reactive Misfolded/Non-Native Zn-Deficient SOD1 Species Exhibit Cytotoxicity and Adopt Heterozygous Conformations in Motor Neurons

Mass spectrometry imaging of SOD1 protein-metal complexes in SOD1G93A transgenic mice implicates demetalation with pathology

Seeding activity of human superoxide dismutase 1 aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking-induced conversion

Construction of a microcavity-based microfluidic chip with simultaneous SERS quantification of dual biomarkers for early diagnosis of Alzheimer's disease

High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation

Surface-functionalized SERS platform for deep learning-assisted diagnosis of Alzheimer's disease

Promoting identification of amyotrophic lateral sclerosis based on label‐free plasma spectroscopy

Label-free Detection of Early Oligomerization of Α-Synuclein and Its Mutants A30P/E46K Through Solid-State Nanopores.

Engineering a monobody specific to monomeric Cu/Zn‐superoxide dismutase associated with amyotrophic lateral sclerosis

Identification and Functional Analysis of Novel Mutations in the SOD1 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.

Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays

Peptoid Nanosheet-Based Sensing System for the Diagnosis and Surveillance of Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

SOD1 Enzymatic Activity in CSF from ALS patients with and without SOD1 mutations

A SERS nanocellulose-paper-based analytical device for ultrasensitive detection of Alzheimer's disease